Tucatinib is an inhibitor that zeros in on HER2-positive breast cancer patients who’ve got brain tumors. It works by stopping the HER2 signaling process. Tucatinib comes in tablet form with two doses: 50 mg and 150 mg.
Adults usually take 300 mg of Tucatinib two times a day, and it’s best to take it with food. Most bottles of Tucatinib hold 60 tablets, so it’s good for the long haul. It’s super important to follow the schedule exactly to keep the cancer from getting too tough to beat.
